Conversion of 4-cyanomethyl-pyrazole-3-carboxamides into CB1 antagonists with lowered propensity to pass the blood-brain-barrier.

Source:http://linkedlifedata.com/resource/pubmed/id/20015647

Bioorg. Med. Chem. Lett. 2010 Jan 15 20 2 453-7

Download in:

View as

General Info

PMID
20015647